Patent approved for CRISPR use in T-cells in Europe
Wednesday, August 2, 2017 - 12:52
in Biology & Nature
The European Patent Office issued a patent today for the use of RNA-guided endonucleases for the genetic engineering of T-cells to Cellectis.